Dr. Menon served at Eli Lilly as Group Leader, Cancer In Vivo Research and Clinical Development. At Lilly, Dr. Menon played a key role in lead selection and pre-clinical development of Gemzar and Alimta, two anti-cancer drugs which have generated billions of dollars in yearly revenue. In addition, Lilly honored Dr. Menon with the prestigious President’s Recognition Award.
The above is from the CTIX web site. Does anybody here have any independent verification of the true nature of these things? Was it more than running an animal testing lab for Lilly?
For those honorable boosters of the management: please hold your peace if you have nothing besides deep-down-inside confidence in the goodness of these gentlemen to contribute.
Market Data 
Markets 
AI
